← Back to Search

Diagnostic Test

Ulrasound Vibroelastography (UVE) for Prostate Adenocarcinoma

N/A

Recruiting

Led By Matthew J. Ziegelmann, M.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 6 months and 9 months post-prostatectomy

Awards & highlights

Study Summary

This trial aims to investigate if adding vibroelastography, a noninvasive ultrasound technique, to the standard penile duplex Doppler ultrasound can help evaluate tissue fibrosis and erectile function recovery after

Who is the study for?

Men over 40 with early-stage prostate cancer (low to intermediate risk) and mild or no erectile dysfunction, as measured by a score of ≥21 on the IIEF. They must be interested in preserving sexual function and planning to undergo nerve-sparing prostatectomy surgery.Check my eligibility

What is being tested?

The trial is testing Ultrasound Vibroelastography (UVE), a noninvasive technique, alongside standard penile duplex Doppler ultrasound to see if it better assesses erectile function recovery after prostate cancer surgery.See study design

What are the potential side effects?

Since UVE is a diagnostic procedure using ultrasound, side effects are minimal but may include discomfort during the procedure or minor skin irritation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, 6 months and 9 months post-prostatectomy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, 6 months and 9 months post-prostatectomy

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months and 9 months post-prostatectomy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Viscoelasticity

Trial Design

1Treatment groups

Experimental Treatment

Group I: Ultrasound viscoelastography (UVE) in radical proctectomy recoveryExperimental Treatment1 Intervention

Subjects undergoing radical prostatectomy for prostate cancer disease as standard of care will have a ultrasound vibroelastography performed before surgery, 3 months, 6 months and 9 months post-prostatectomy.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,216 Previous Clinical Trials

3,767,478 Total Patients Enrolled

Matthew J. Ziegelmann, M.D.Principal InvestigatorMayo Clinic

Matthew Ziegelmann, MDPrincipal InvestigatorMayo Clinic

2 Previous Clinical Trials

192 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals presently able to enroll in this clinical trial?

"As detailed on clinicaltrials.gov, this particular research study is currently seeking eligible participants. The trial was first listed on October 2nd, 2023 and the latest update occurred on March 12th, 2024."

Answered by AI

What is the upper limit of participants involved in this clinical investigation?

"Indeed, information on clinicaltrials.gov confirms the active recruitment status of this trial. The study was initially posted on October 2nd, 2023 and last revised on March 12th, 2024. It aims to enroll a total of 10 patients from one research site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction

Matthew (Matt) J. Ziegelmann 2023. "The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05109208.

All > Erectile Dysfunction